Campbell & Co. Investment Adviser »

Mineralys Therapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2025-12-31 $523k 14k 36.29

More positions owned by Campbell & Co. Investment Adviser

Itt Common Stock (ITT)
Cheniere Energy Common Stock (LNG)
United Rentals Common Stock (URI)
BHP Group Adr (BHP)
Cullen/Frost Bankers Common Stock (CFR)
Pool Corp Common Stock (POOL)
Ameris Bancorp Common Stock (ABCB)
Bank of America Corp Common Stock (BAC)
Aecom Common Stock (ACM)
Associated Banc-Corp Common Stock (ASB)
DTE Energy Common Stock (DTE)
Netflix Common Stock (NFLX)
Allstate Corp/The Common Stock (ALL)
Labcorp Holdings Common Stock (LH)
Southwest Airlines Common Stock (LUV)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics